1. Home
  2. TNGX vs FSBW Comparison

TNGX vs FSBW Comparison

Compare TNGX & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • FSBW
  • Stock Information
  • Founded
  • TNGX 2014
  • FSBW 1936
  • Country
  • TNGX United States
  • FSBW United States
  • Employees
  • TNGX N/A
  • FSBW N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • FSBW Banks
  • Sector
  • TNGX Health Care
  • FSBW Finance
  • Exchange
  • TNGX Nasdaq
  • FSBW Nasdaq
  • Market Cap
  • TNGX 413.6M
  • FSBW 355.0M
  • IPO Year
  • TNGX N/A
  • FSBW 2012
  • Fundamental
  • Price
  • TNGX $3.04
  • FSBW $41.92
  • Analyst Decision
  • TNGX Strong Buy
  • FSBW Hold
  • Analyst Count
  • TNGX 8
  • FSBW 1
  • Target Price
  • TNGX $13.14
  • FSBW $44.00
  • AVG Volume (30 Days)
  • TNGX 1.5M
  • FSBW 15.0K
  • Earning Date
  • TNGX 11-06-2024
  • FSBW 01-22-2025
  • Dividend Yield
  • TNGX N/A
  • FSBW 2.59%
  • EPS Growth
  • TNGX N/A
  • FSBW 8.77
  • EPS
  • TNGX N/A
  • FSBW 4.68
  • Revenue
  • TNGX $43,383,000.00
  • FSBW $139,457,000.00
  • Revenue This Year
  • TNGX $27.73
  • FSBW N/A
  • Revenue Next Year
  • TNGX N/A
  • FSBW $6.26
  • P/E Ratio
  • TNGX N/A
  • FSBW $8.96
  • Revenue Growth
  • TNGX 15.67
  • FSBW 2.60
  • 52 Week Low
  • TNGX $2.70
  • FSBW $30.64
  • 52 Week High
  • TNGX $13.01
  • FSBW $49.15
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 39.30
  • FSBW 35.02
  • Support Level
  • TNGX $2.72
  • FSBW $40.00
  • Resistance Level
  • TNGX $3.29
  • FSBW $43.00
  • Average True Range (ATR)
  • TNGX 0.30
  • FSBW 1.35
  • MACD
  • TNGX 0.07
  • FSBW -0.50
  • Stochastic Oscillator
  • TNGX 32.08
  • FSBW 29.36

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking, and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: